About the compound
Khavinson tetrapeptide bioregulator KEDA. C₁₉H₃₃N₅O₈, MW 459.50 Da.
Livagen is a Khavinson tetrapeptide with the sequence Lys-Glu-Asp-Ala. Empirical formula C₁₉H₃₃N₅O₈; MW 459.50 Da.
Reconstitution. For in-vitro laboratory handling, dissolve with bacteriostatic water (0.9% benzyl alcohol). Compound is hygroscopic — handle in low-humidity conditions and re-cap immediately.
Stability profile. Lyophilized: stable at room temperature for up to 30 days sealed; long-term storage at -20 °C recommended. Reconstituted material: stable at 2–8 °C for up to 14 days.
Selected primary literature.
- Khavinson VK, 2002, Neuroendocrinol Lett 23 Suppl 3:11 — structural characterization of the KEDA tetrapeptide (preclinical).
What remains uncharacterized: concentration-response relationships in any specific in-vitro model system are not implied here. The literature cited above describes molecular-level observations only.
For research use only. Not for human or animal consumption.




